Jasper Therapeutics Inc - Warrant — Financial Statements (NASDAQ:JSPRW)

Financials

Total revenue —80 K16.58 M246 K8.3 M — Gross profit —80 K16.58 M246 K8.3 M — Operating expenses 4.44 M36.83 M51.2 M68.86 M76.24 M 93.33 M Selling/general/admin expenses 935.4 K11.41 M19.24 M17.08 M20.42 M 21.81 M Research & development —25.42 M34.63 M51.78 M55.82 M 71.52 M Operating income 935.4 K36.83 M51.2 M68.86 M76.24 M 93.33 M Non-Operating Income, Total 383.15 K—586 K5.2 M4.97 M 2.31 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 0—05.2 M4.88 M 176 K Unusual income/expense 383.15 K—586 K—88 K 2.13 M Pretax income 552.25 K36.83 M51.78 M74.06 M81.21 M 95.64 M Equity in earnings ————— — Taxes 38.45 K0002 000 — Non-controlling/minority interest ————— — After tax other income/expense ———419 K-491 K -964 K Net income before discontinued operations 590.7 K30.64 M37.69 M64.47 M71.27 M 91.02 M Discontinued operations ————— — Net income 590.7 K30.64 M37.69 M64.47 M71.27 M 91.02 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 590.7 K30.64 M37.69 M64.47 M71.27 M 91.02 M Basic earnings per share (Basic EPS) ——-10.3-6.18-4.89 -5.93 Diluted earnings per share (Diluted EPS) —181.23-10.3-6.18-4.89 -5.93 Average basic shares outstanding —-96.99 K3.65 M10.44 M14.58 M 61.58 M Diluted shares outstanding —169.05 K3.65 M10.44 M14.58 M 61.58 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) —400 K1 M1.1 M— —